Pharmacokinetics

After 25 years of drug development, do we know JAK?
Mahta Mortezavi, David A Martin, Hendrik Schulze-Koops

RMD Open Jul 2022, 8 (2) e002409; DOI: 10.1136/rmdopen-2022-002409
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
Charlotte Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, Guillaume le Mélédo, Alejandro Balsa, Meghna Jani, Denis Mulleman, Victoria Navarro-Compan, Gertjan Wolbink, John Isaac, Astrid van Tubergen

RMD Open Jun 2022, 8 (2) e002216; DOI: 10.1136/rmdopen-2022-002216
Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis
Johanna Elin Gehin, Silje Watterdal Syversen, David John Warren, Guro Løvik Goll, Joseph Sexton, Nils Bolstad, Hilde Berner Hammer

RMD Open Dec 2021, 7 (3) e001985; DOI: 10.1136/rmdopen-2021-001985
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study
Roy Fleischmann, Peter Winkle, Jeffrey N Miner, Xiaohong Yan, Liz Hicks, Shakti Valdez, Jesse Hall, Sha Liu, Zancong Shen, Michael Gillen, Martha Hernandez-Illas

RMD Open Feb 2018, 4 (1) e000584; DOI: 10.1136/rmdopen-2017-000584
Serious neurological events complicating epidural injections of glucocorticoid suspensions: evidence for a direct effect of some particulate steroids on red blood cells
Jean-Denis Laredo, Elisabeth Laemmel, Eric Vicaut

RMD Open Sep 2016, 2 (2) e000320; DOI: 10.1136/rmdopen-2016-000320
Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures
Joel M Kremer, David A Lawrence, Robert Hamilton, Iain B McInnes

RMD Open Jun 2016, 2 (1) e000287; DOI: 10.1136/rmdopen-2016-000287
Biosimilars in rheumatology: what the clinician should know
Gilberto Castañeda-Hernández, Rodrigo González-Ramírez, Jonathan Kay, Morton A Scheinberg

RMD Open May 2015, 1 (1) e000010; DOI: 10.1136/rmdopen-2014-000010

Log in using your username and password

Main menu

Log in using your username and password

You are here

Pharmacokinetics